STS-ACC TVT registry of transcatheter aortic valve replacement

JD Carroll, MJ Mack, S Vemulapalli… - Journal of the American …, 2020 - jacc.org
… The Registry is a national resource to improve care and analyze TAVR’s evolution. Real-world
outcomes, site performance, and the impact of coronavirus disease 2019 will be …

Transcatheter mitral valve therapy in the United States: a report from the STS-ACC TVT registry

M Mack, JD Carroll, V Thourani, S Vemulapalli… - Journal of the American …, 2021 - jacc.org
… The data definitions for the mitral valve modules are available at the registry’s website (7).
Definitions are according to those published by the Valve Academic Research Consortium (8), …

Secondary hormonal therapy for advanced prostate cancer

JS Lam, JT Leppert, SN Vemulapalli, O Shvarts… - The Journal of …, 2006 - Elsevier
PURPOSE: Androgen ablation remains the cornerstone of management for advanced
prostate cancer. Therapeutic options in patients with progressive disease following androgen …

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo …

…, R Mathews, R Mehta, WS Jones, S Vemulapalli… - The Lancet, 2018 - thelancet.com
Background Glucagon-like peptide 1 receptor agonists differ in chemical structure, duration
of action, and in their effects on clinical outcomes. The cardiovascular effects of once-weekly …

All-digital PLL and transmitter for mobile phones

…, CM Hung, OE Eliezer, SK Vemulapalli… - IEEE journal of Solid …, 2005 - ieeexplore.ieee.org
We present the first all-digital PLL and polar transmitter for mobile phones. They are part of
a single-chip GSM/EDGE transceiver SoC fabricated in a 90 nm digital CMOS process. The …

Clinical outcomes at 1 year following transcatheter aortic valve replacement

…, JS Rumsfeld, D Dai, SM O'Brien, S Vemulapalli… - Jama, 2015 - jamanetwork.com
Importance Introducing new medical devices into routine practice raises concerns because
patients and outcomes may differ from those in randomized trials. Objective To update the …

Annual outcomes with transcatheter valve therapy: from the STS/ACC TVT registry

…, VH Thourani, EM Tuzcu, S Vemulapalli… - Journal of the American …, 2015 - jacc.org
Vemulapalli has received research grant support from Boston Scientific; has received
funding for travels from Abbott Vascular; and received payment for travel from Philips Medical …

2016 annual report of the Society of Thoracic Surgeons/American College of Cardiology transcatheter valve therapy registry

FL Grover, S Vemulapalli, JD Carroll… - Journal of the American …, 2017 - jacc.org
Vemulapalli has received research grants from Abbott Vascular, the American College of
Cardiology, and The Society of Thoracic Surgeons; and has served as a consultant for Novella …

1.3 V 20 ps time-to-digital converter for frequency synthesis in 90-nm CMOS

RB Staszewski, S Vemulapalli, P Vallur… - … on Circuits and …, 2006 - ieeexplore.ieee.org
We propose and demonstrate a 20-ps time-to-digital converter (TDC) realized in 90-nm digital
CMOS. It is used as a phase/frequency detector and charge pump replacement in an all-…

Outcomes with transcatheter mitral valve repair in the United States: an STS/ACC TVT registry report

P Sorajja, S Vemulapalli, T Feldman, M Mack… - Journal of the American …, 2017 - jacc.org
Background : Post-market surveillance is needed to evaluate the real-world clinical effectiveness
and safety of US Food and Drug Administration–approved devices. Objectives : The …